Prevention and Management of Antineoplastic-Induced Hypersensitivity Reactions

ISSN： 0114-5916

Source： Drug Safety, Vol.24, Iss.10, 2001-01, pp. : 767-779

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hypersensitivity to Antineoplastic Agents

Current Pharmaceutical Design, Vol. 14, Iss. 27, 2008-09 ,pp. : 2892-2901

Bentham Science Publishers

Access to resources Recommend Favorite

Anticonvulsant Hypersensitivity Syndrome: Incidence, Prevention and Management

By Knowles S.R.

Drug Safety, Vol. 21, Iss. 6, 1999-12 ,pp. : 489-501

Adis International

Access to resources Recommend Favorite

Anticonvulsant Hypersensitivity Syndrome in Children: Incidence, Prevention and Management

By Verrotti A. Trotta D. Salladini C. Chiarelli F.

CNS Drugs, Vol. 16, Iss. 3, 2002-01 ,pp. : 197-205

Adis International

Access to resources Recommend Favorite

Hapten-induced hypersensitivity reactions in the airways: atopic versus non-atopic

By van Houwelingen A.H. Kraneveld A.D. Nijkamp F.P.

Environmental Toxicology and Pharmacology, Vol. 11, Iss. 3, 2002-07 ,pp. : 197-205

Elsevier

Access to resources Recommend Favorite

Docetaxel-induced acute hypersensitivity reactions do not appear to be of an allergic nature

Reactions Weekly, Vol. 1, Iss. 1016, 2004-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite